Study Reveals Choroidal Involvement in Most Thyroid Cancer Metastasis Cases
The Clinical Significance of Ectopic Bone Formation in MTC Explored
RET Mutation Screening May Uncover MTC and Other Malignancies
18F-FDOPA PET/CT May Effectively Predict Recurrence of MTC
Immunologic Markers May Be Used in MTC Prognosis
Study Reviews the Effects of Tyrosine Kinase Inhibitors in MTC Treatment
Study Compares Features of Rare Types of Thyroid Carcinoma
Liquid Biopsy May Help Predict Prognosis in Medullary Thyroid Carcinoma
MTC May Have Several Biomarkers Aside From Calcitonin
Latest Clinical Trials
Treating Advanced Medullary Thyroid Carcinoma
While surgical resection is not an option for patients with metastasized MTC, newer therapies may prolong survival and improve life.
Exploring the Parental Burden of Care of Children With Rare Diseases
The parental burden of care of children with rare diseases is considerable and deserves due attention and support.
The Prognostic Value of Lymph Node Ratios in Medullary Thyroid Carcinoma
Two separate studies investigated the prognostic role of lymph node ratios in patients with medullary thyroid carcinoma.
Accepting When a Dignified Death Is Best
I was faced with a very rare type of cancer when I was diagnosed with medullary thyroid cancer (MTC).
MTC, Other Cancers Have a Shadow Life
Most who are affected by cancer will experience a less rare form of cancer than mine, medullary thyroid carcinoma (MTC).
Lessons Learned After Radiation for My MTC
I previously wrote a similar column about radiation and some of the effects it had on me during treatment for medullary thyroid cancer (MTC).
Omidubicel Shows Promise as Replacement for Umbilical Cord Blood in Stem Cell Transplants
Gamida Cell is gearing up to begin sales of omidubicel from Israel to US hospitals for use in stem cell transplants, pending FDA approval of the therapy.
The Alliance for Regenerative Medicine Fights for Better Cell, Gene Therapies
The Alliance for Regenerative Medicine aims to help in the development of safe and effective regenerative therapies that can benefit rare disease patients.
Thyroid Expert Outlines Best Options for MTC Diagnosis, Surgery
Dr. Haggi Mazeh, chief of surgery at one of Israel’s top hospitals, discusses diagnosing and treating medullary thyroid carcinoma.
Management of Medullary Thyroid Carcinoma Possible, if Caught in Time
MTC “can get aggressive and nasty” but it is not necessarily a death sentence, said surgical oncologist David Goldenberg, MD, FACS, author of a new book.
Rare Care Podcast
Endocrine Surgeon Dr. Haggi Mazeh Describes the Challenges of Treating MTC